Physician profile

Jose Alemparte

Fort Smith, AR

NPI 1679574255

$11,997.09

in general payments reported to CMS, 2019-2025

31 companies · $898 in 2025

The $898 reported for 2025 was more than what 87% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,858.52

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,973.60 2019-2025 Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Farapulse
Novartis Pharmaceuticals Corporation $1,577.28 2019-2025
Medtronic, INC. $1,245.36 2021-2025 Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan
Amgen INC. $933.46 2019-2023 Repatha
Janssen Pharmaceuticals, INC $874.99 2019-2024 Xarelto
Boehringer Ingelheim Pharmaceuticals, INC. $863.08 2020-2025 Jardiance, Spiriva Respimat, Stiolto Respimat
Merck Sharp & Dohme LLC $655.63 2021-2025 Verquvo, Belsomra, Steglatro
Medtronic Vascular, INC. $560.37 2019-2020
Sanofi-Aventis U.S. LLC $554.36 2019-2024
Abiomed $535.39 2022-2024 Impella
Pfizer INC. $444.77 2019-2025
Bayer Healthcare Pharmaceuticals INC. $395.10 2022-2025
Astrazeneca Pharmaceuticals LP $374.73 2019-2022
Astellas Pharma US INC $263.76 2019-2021
E.R. Squibb & Sons, L.L.C. $223.50 2021-2025 Camzyos, Eliquis
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Shockwave Medical, INC $112.47 2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Esperion Therapeutics, INC. $74.75 2020-2021
Novo Nordisk INC $52.74 2023-2024 Ozempic, Rybelsus
Lilly USA, LLC $44.84 2019-2023 Jardiance
Philips North America LLC $43.09 2024 (Ck7) Extended Holter
Lexicon Pharmaceuticals, INC. $32.62 2023-2024 Inpefa
Regeneron Healthcare Solutions, INC. $32.14 2019
Gilead Sciences, INC. $22.69 2019
Eisai INC. $17.22 2020
Lundbeck LLC $16.99 2019
Alnylam Pharmaceuticals INC. $15.66 2020
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $12.48 2021
Neurocrine Biosciences, INC. $11.94 2019
Amarin Pharma, INC. $11.86 2019
Zyla Life Sciences, INC. $11.54 2019
Cashflow Solutions, LLC $8.68 2024 Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jose Alemparte

$11,997.09

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $898 reported for 2025 was more than what 87% of providers received nationally.

https://glasscript.com/doctor/30809/jose-alemparte

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.